SCHEMBL23657482

SCHEMBL23657482

O=C(Nc1cc(=O)c2ccccc2o1)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 3/20 0.55
GAA P10253 2/20 0.55
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
LMNA P02545 3/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
MAOB P27338 2/20 0.54
ACHE P22303 1/20 0.54
HTT P42858 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TNKS O95271 1/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
TDP1 Q9NUW8 1/20 0.50
MAPT P10636 3/20 0.49
TP53 P04637 1/20 0.49
MAOA P21397 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28653479 0.83 TDP1 (0.70) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL29923734 0.83 TDP1 (0.70) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL12325324 0.77 KDM4E (0.66) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL11398949 0.77 KDM4E (0.62) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL11388357 0.76 KDM4E (0.60) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL21174969 0.75 LMNA (0.80) KDM4ENPC1RAB9ALMNAHTT
SCHEMBL11388353 0.74 KDM4E (0.63) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL28032478 0.74 KDM4E (0.75) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL11856459 0.74 KDM4E (0.59) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL29622957 0.74 ALDH1A1 (0.53) ALDH1A1KDM4EGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210220408-A1 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE EDIGENE BIOTECHNOLOGY, INC. (CN) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210220408-A1 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE AHR, ARNT, ARSA ALDH1A1 98/4885KDM4E 1784/4885GAA 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.